Nivolumab-induced palmoplantar and hypertrophic Lichen Planus in Patients with Metastatic Renal Cell Carcinoma

被引：0
|
作者：
Schmidgen, M. [1 ]
Stege, H. [1 ]
Bradfi, Sch F. [1 ]
Henning, B. [1 ]
Grabbe, S. [1 ]
Weidenthaler-Barth, B. [1 ]
Saloga, J. [1 ]
Loquai, C. [1 ]
机构：
[1] Univ Med Mainz, Hautklin & Poliklin, Mainz, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2017年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P17
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] Severe immune thrombocytopenia induced by nivolumab in a patient with metastatic renal cell carcinoma
    Hata, Shinro
    Abe, Satoki
    UROLOGY CASE REPORTS, 2020, 32
  • [42] PD-1 inhibitor Nivolumab-induced squamous cell carcinoma
    Jacobsen, A.
    Strasswimmer, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (08) : B12 - B12
  • [43] Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
    Choueiri, Toni K.
    Fishman, Mayer N.
    Escudier, Bernard
    McDermott, David F.
    Drake, Charles G.
    Kluger, Harriet
    Stadler, Walter M.
    Perez-Gracia, Jose Luis
    McNeel, Douglas G.
    Curti, Brendan
    Harrison, Michael R.
    Plimack, Elizabeth R.
    Appleman, Leonard
    Fong, Lawrence
    Albiges, Laurence
    Cohen, Lewis
    Young, Tina C.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Srivastava, Shivani
    Jure-Kunkel, Maria
    Kurland, John F.
    Simon, Jason S.
    Sznol, Mario
    CLINICAL CANCER RESEARCH, 2016, 22 (22) : 5461 - 5471
  • [44] An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma
    Zarrabi, Kevin
    Wu, Shenhong
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (06) : 695 - 705
  • [45] Nivolumab undergoing Phase I testing in metastatic renal cell carcinoma patients
    Nagda, Priti
    FUTURE ONCOLOGY, 2013, 9 (08) : 1070 - 1070
  • [46] Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab
    Catalano, Martina
    Rebuzzi, Sara Elena
    Maruzzo, Marco
    De Giorgi, Ugo
    Buti, Sebastiano
    Galli, Luca
    Fornarini, Giuseppe
    Zucali, Paolo Andrea
    Procopio, Giuseppe
    Chiellino, Silvia
    Milella, Michele
    Catalano, Fabio
    Pipitone, Stefania
    Ricotta, Riccardo
    Soraru, Mariella
    Mollica, Veronica
    Tudini, Marianna
    Fratino, Lucia
    Prati, Veronica
    Caffo, Orazio
    Atzori, Francesco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Di Napoli, Marilena
    Malgeri, Andrea
    Naglieri, Emanuele
    Signori, Alessio
    Banna, Giuseppe Luigi
    Rescigno, Pasquale
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    JAMA NETWORK OPEN, 2023, 6 (11) : E2345185
  • [47] Inflammatory markers for predicting responses to nivolumab in patients with metastatic renal cell carcinoma
    Ikarashi, Daiki
    Kato, Yoichiro
    Kato, Renpei
    Kanehira, Mitsugu
    Takata, Ryo
    Obara, Wataru
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (04) : 350 - 351
  • [48] Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy
    Yoshida, Kazuhiko
    Takagi, Toshio
    Kondo, Tsunenori
    Kobayashi, Hirohito
    Iizuka, Junpei
    Fukuda, Hironori
    Ishihara, Hiroki
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (06) : 576 - 580
  • [49] Changes of TCR repertoire in metastatic renal cell carcinoma and metastatic melanoma patients treated with nivolumab
    Klabusay, M.
    Skacel, J.
    Coupek, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Giant renal cell carcinoma in a patient with ipsilateral lower limb hypertrophic lichen planus; Case report and literature review
    Popescu, Silvia
    Peta, Dumitru
    Kover, Zoltan Janos
    Toma, Dumitru
    Cristea, Ioan-Teodor
    Popescu, Mihaela Anca
    Balalau, Oana-Denisa
    Sima, Romina-Marina
    Gorecki, Gabriel-Petre
    Giurcaneanu, Calin
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2023, 10 (02): : 356 - 363
12345